COURSE DESCRIPTION:
Join Dr. Nuwan Gunawardhana for a timely presentation on the frontline evaluation and management of suspected Ebola virus disease in the emergency department. Through the lens of a New York City Level 4 National Special Pathogen System (NSPS) facility, this session will review the “Identify, Isolate, Inform” approach, diagnostic considerations, and the coordinated processes required to safely manage and transfer patients with high-consequence infectious diseases. Don't miss this opportunity to strengthen your preparedness for special pathogen events.
TARGET AUDIENCE:
Internal Medicine Physicians, Cardiologists, Pulmonologists, Oncologists, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, and all other interested healthcare providers
LEARNING OBJECTIVES:
- Identify key epidemiologic risk factors and clinical features that should raise suspicion for Ebola virus disease in the emergency department.
- Explain the structure and function of NSPS tiered facilities and their role in preparedness and response to special pathogens.
- Demonstrate use of the "Identify, Isolate, Inform" approach for the safe management of patients under investigation for Ebola virus disease.
- Select appropriate laboratory testing and biosafety procedures for suspected viral hemorrhagic fever cases.
- Coordinate the safe transfer of patients requiring advanced Ebola care to a designated Level 1 NSPS facility in New York State.
FACULTY AND DISCLOSURES:
Nuwan Gunawardhana, M.D.
Assistant Professor of Medicine
Division of Infectious Diseases and Hospital
Epidemiologist
Columbia Irving Medical Center
New York, New York
Nuwan Gunawardhana, M.D., faculty for this activity, is a surveyor for Shionogu U.S. Medical and has indicated that the presentation or discussion will not include off-label or unapproved product usage. All the relevant financial relationships have been mitigated.
John F. Rubin, M.D., FACP, director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible companies – Companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer
ACCREDITATION STATEMENTS AND CREDITS
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-1296402, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.
This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Laboratory Personnel, Athletic Trainers and Respiratory Techs. Baptist Health South Florida CE Broker Provider #50-182.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Florida Board of Athletic Training
- 1.00 General certificate of attendance
- 1.00 Florida Board of Dentistry
- 1.00 Florida Board of Laboratory Personnel
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Occupational Therapy
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy

Facebook
X
LinkedIn
Forward